Autoimmune connective tissue disorder manifestations: Implications for the dental provider – Group License

Description

Reported incidence and prevalence of connective tissue disorders (CTDs) are variable due to different study methodologies, surveyed to be present in 0.015%–3% of the population. CTDs include systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SS), inflammatory muscle diseases, and other overlap syndromes that cause inflammation, autoimmune processes, and/or systemic clinical phenotype involving several organs, as well as polymyositis and dermatomyositis. CTDs, although considered rare, are potentially life-threatening. Therefore, early diagnosis is essential if possible. Current classification criteria do not allow for convenient or proper diagnosis in all patients; nonetheless, they are supportive clinical tools to lead providers to proper diagnoses and to potentially save lives.

Educational objectives

• Outline prevalence and incidence of connective tissue disorders and the implications regarding periodontal conditions.
• Illustrate the systemic signs and symptoms of connective tissue disorders.
• Synthesize cotherapeutic management of connective tissue disorders and periodontal disease.
• Elaborate counseling strategies for dental providers to translate to patients with connective tissue disorders.